Ayala Pharmaceuticals Inc (ADXS)

[Meishairwin]

The stock is worth what people will pay for it, no more, no less. Do I think the pps could get to $25 before EU renders a decision on the anticipated application? It could. A partnership with more substantial upfront cash than Amgen provided could move the pps. How much? Hard to say. Aratana approval could move the pps. How much? I haven't done the calculation because I honestly don't care. Anything else? Not that's obvious, although we could get some Ph1/Ph2 results from the DUAL or PSA or anal, NEO, etc. trials which, if good would move the pps significantly. Will we? Hard to know. Many unknowns and may well not happen timely or strongly to our favor.

So, sure, there are lots of possibilities. My "end point" is not a pps number, per se, but rather the judgment of the ADXS BOD and Adage when they believe it's time to monetize the investment. I'm not expecting that before 2020. I'm a "venture" investor and accept investments like these take 5-7 years from when I inv st to pay off. I first invested in ADXS in 2015, so it's early in the game for me. Of course, I'd exit if trial data are not good.